Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit ... absolute risk and an 11% lower relative risk of kidney function decline to an estimated ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

Without a reliable way to self-regulate blood glucose levels, patients are forced to live with a high-maintenance regimen of ...

and novel agents (e.g. tirapazamine, EGFR inhibitors and other targeted agents) with radiotherapy will be examined. This article is part one of two articles. In the subsequent article, the general ...

Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

Long-term exposure to high levels of particulate matter (PM2.5), industrial emissions ... Specific genetic mutations, such as those found in the EGFR gene, are more common in non-smokers, especially ...

Detailed price information for Lexicon Pharmaceutcl (LXRX-Q) from The Globe and Mail including charting and trades.